Options
Methods and effectiveness of oxygen therapy for patients with COVID-19 in the Hospital of Lithuanian University of Health Sciences Kauno Klinikos, the Department of Anaesthesiology
Date Issued |
---|
2021-04-29 |
Anaesthesiology and Intensive Care session
Abstracts’ reviewers: p. 6 (143)
Bibliogr.: p. 18
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been established as a cause of severe alveolar damage and pneumonia in patients with COVID-19. Management of respiratory failure include supplemental oxygen, oxygen delivered through high flow nasal cannulas, non-invasive positive pressure ventilation (NIPPV) and intubation [1, 2]. The wide variation in mortality rates across different intensive care units raises the possibility that the approach to ventilatory management could be contributing to the outcome of the patients [3]. Aim To analyze and to present features of therapeutic oxygen therapy and outcome of the patients with COVID-19. Methods The research was carried out with the permission of the Hospital of Lithuanian University of Health Sciences Centre of Bioethics (No. BEC-MF-232) from November of 2020 to February of 2021. Data was collected from the depersonalized medical histories of 101 patients that were treated in the Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Department of Anaesthesiology, COVID-19 sector ICU. The collected data include the sex of research subjects, their age, comorbidities, application of measures to ensure and maintain their respiratory function and methods of oxygen therapy they have received while in the ICU. The data were analysed using the Microsoft Excel software. Results The study involved 101 patients: 52,5% men and 47,5% women. The average age of the patients was 66,31 years. The majority of the patients (94,1%) were multimorbid with comorbidities in cardiovascular (46,1%), kidneys and urinary (21,1%), gastrointestinal (18,9%), neurological (9,5%) systems and oncological (16,8%) diseases. 56,8% of them had two or more comorbidities. 72,82% of the patients had respiratory failure. All of the patients with respiratory failure have received treatment for it. 48,7% of all patients received combination oxygen therapy. 46,2[...].